On June 14, 2016, CARMA hosted an event in New York City that posed the question: How important is reputation to the Pharmaceutical industry? Many firms in the sector have gone through scandals involving corruption, test data falsification, bribery and more without losing substantial traction in the markets – events which might have paralysed other industries.

Our research shows that, globally, critics of the industry are growing stronger, opposition to certain practises is growing harsher and the regulatory and political attitudes persistently challenging for the industry. This conference will examine how critical good reputation really is to the sector, what to do in the face of reputational loss and how to sustain strong reputational capital.

Leave a Reply

Your email address will not be published. Required fields are marked *

clear formPost comment